Get started
jfs2152

VBIV target [$3.50] by July 1st

Long
VBI Vaccines, Inc. (NASDAQ:VBIV)  
jfs2152 Updated   
NASDAQ:VBIV   VBI Vaccines, Inc.
Trend Analysis Chart Patterns Technical Indicators VBIV biotech pump LONG Coronavirus (COVID-19) recovery pharmaceuticals vaccine
13
9
trendanalysis chartpattern indicator vbiv biotech pump long coronavirus recovery pharmaceuticals vaccine
Expect a significant appreciation in price leading up to the upcoming poster presentation of Phase 1/2a data of VBI-1901 in Recurrent GBM Patients at AACR virtual annual meeting.
Comment:
Large MACD divergence into what seems like price consolidation. Expecting a big move within the next 3-5 days.

snapshot

Related Ideas

jfs2152
LABU (XBI) LONG - Price Target: $70.
jfs2152 about LABU 3
jfs2152
Wall Street is Short VBIV, but I'm Long *Target: [$3.50]*
jfs2152 about VBIV 5
jfs2152
Will this be a great VBIV buy in?
jfs2152 about VBIV 2
jfs2152
VBIV day trade [Price Target: $1.60]
jfs2152 about VBIV 3
jfs2152
VBIV break out [$1.50 target]
jfs2152 about VBIV 3
jfs2152
VBI vaccines $4 EOY Target
jfs2152 about VBIV 2
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.